Ovid Therapeutics Inc (OVID)

1.890
-0.070(-3.57%)
After Hours
1.850
-0.040(-2.116%)
- Real-time Data
  • Volume:
    595,228
  • Day's Range:
    1.850 - 1.950
  • 52 wk Range:
    1.850 - 4.800

OVID Overview

Prev. Close
1.96
Day's Range
1.85-1.95
Revenue
209.83M
Open
1.93
52 wk Range
1.85-4.8
EPS
-0.99
Volume
595,228
Market Cap
133.79M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
157,803
P/E Ratio
-
Beta
1.63
1-Year Change
-50.25%
Shares Outstanding
70,417,345
Next Earnings Date
Aug 11, 2022
What is your sentiment on Ovid Therapeutics?
or
Market is currently closed. Voting is open during market hours.

Ovid Therapeutics Inc News

Ovid Therapeutics Inc Analysis

Ovid Therapeutics Inc Company Profile

Ovid Therapeutics Inc Company Profile

Employees
57

Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment of seizures associated with tuberous sclerosis complex and infantile spasms; and OV350, a small molecule for treating epilepsies. It also develops OV882, a short hairpin RNA gene therapy for the treatment of angelman syndrome; and OV815 for the treatment of kinesin-family of proteins associated neurological disorder. The company has license and collaboration agreements with Healx, AstraZeneca AB, H. Lundbeck A/S, and Northwestern University, as well as Marinus Pharmaceuticals, Inc. The company was incorporated in 2014 and is headquartered in New York, New York.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellSellStrong SellStrong SellStrong Sell
Technical IndicatorsStrong BuyStrong SellStrong SellStrong SellStrong Sell
SummaryStrong SellStrong SellStrong SellStrong SellStrong Sell
  • 7 nice target
    0
    • Next target 7.00$
      0
      • expected to rise till ?
        0
        • Hugh Mckane doubt its gonna happen overnight, probably by friday
          0
        • Irshat Mukhametov 15 by friday is still alot though... then its a strong buy?
          0
        • Dong ThreeThousand I guess so, 15 is aligned with 1 bill valuation, which with money the co is expected to recieve from Takeda is quite achievable
          0
      • Letsgo back
        0
        • 250k$ just removed. thanks to OVID.
          1
          • Sorry for your loss. Watch prvb pre fda approval. Good luck!
            0
          • Gene Emory what is prvb? i lost 25k, and so sad.
            0
          • i hope next 10 bagger
            0
        • to where
          0
          • Buy
            1
            • why?
              0
          • Why is this stock falling so much?
            0
            • Bc of stock offering to cover expenses due to no revenue and missed on EPS. Its a long hold. Will make you lots of money when trials are over.
              1
            • Agreed. The question is it 2 year or 5 years hold.
              0
          • People suggested selling @ 8 but i bought at 3 with target of 20. Not sure if I should hold or sell...
            0
            • now avg target is 13.6, high is 21$
              0
          • great day today. I'm not going to pretend to know why it went up, but I hope it was painful for the short sellers.
            0